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Action of Pentoxifylline on Experimental Cutaneous
Leishmaniasis Due to Leishmania
(Leishmania) amazonensis
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In the animal model of leishmaniasis caused by Leishmania (Leishmania) amazonensis there is a
complex mechanism of the host-parasite interaction. The present study was performed to interfere with
the inflammatory reaction to the parasites, through immune modulation. Female C5BL/6 isogenic mice
were used, some of which were inoculated on the right ear and others on the right footpad with 3.106
stationary phase promastigotes of the MHOM/BR/PH8 strain of  L. (L.) amazonensis, and were allocated
in three groups: the first received pentoxifylline 8mg/kg every 12 h, since the first day; the second one
received the same dose since the 40th day of infection and a control group that did not receive any
treatment. All the ears excised were analyzed to determine the variation in weight between both ears
and for histopathological analyses. A quantification of the parasites was done using the limiting
dilution assay. A significant reduction of the number of parasites, was observed among the animals
treated which had an accordingly significant reduction on the weight of the ears. Pentoxifylline reduced
the macrophages propensity to vacuolation and induced a more effective destruction of the parasites by
these cells. Moreover, the group that began the treatment later did not show the same effectiveness.
Key words: pentoxifylline - Leishmania (Leishmania) amazonensis - tumour necrosis factor-alpha
On the experimental infections with protozoal
of the genus Leishmania, the host’s resistance or
susceptibility to the parasite is determined by the
response offered by the T lymphocytes of the Th 1
subset or the Th 2 subset (Mukherjee et al. 1990,
Solbach & Laskay 1996). In fact, it has been shown
that cellular based immunity is the main mechanism
of defense against these protozoa (Liew et al. 1990a).
In general, intracellular parasitism is associated with
the induction of the Th 1 subset response [includ-
ing the cytokines interleukin-1 (IL-1), IL-2, IL-12,
interferon-gamma (IFN-γ), tumour necrosis factor-
alpha (TNF-α)] though it may also occur due to the
Th 2 subset response [including the cytokines IL-
6, IL- 9, IL- 10, transforming growth factor-beta
(TGF-β), IL- 13] (Sullivan et al. 1988, Liew 1990b,
Cerami 1992, Barral-Netto & Barral 1994, Borish &
Rosenwasser 1996, Solbach & Laskay 1996, Van
Furth et al. 1997).
In order to perform the experiment, we used
pentoxifylline xanthine (Trental ®) which is able to
function in a variety of cells, including macroph-
ages, NK cells and neutrophils and causes distinct
effects on each type.  Among the main cellular ac-
tions determined by this drug are modulations in
the production of cytokines. In fact, it inhibits, in a
dose-dependent manner, the synthesis of TNF-α
by macrophages (Reed & Degowin 1992), the syn-
thesis of IL-2, IL-12 and INF-γ, and influences the
production of other cytokines, such as IL-4, IL-6
and IL-10 (Strieter et al. 1988, Neuner et al. 1994).
These observations indicate that pentoxifylline acts
by stimulating changes in the cellular response from
the Th 1 subset to the Th 2 subset. The extrinsic
modulation of the immune response induced by
this drug may help in the search for a better under-
standing of the meaning of the participation of the
cells in the pathogenesis of the disease and of the
factors released by them, mainly the cytokines.
Pentoxifylline xanthine has an important action
on the polymorphonuclear leukocytes, mainly
through neutralization of the stimulating effects of
IL-1 (Weinberg et al. 1992) and TNF-α upon the
cells (Strieter et al. 1988, Varani et al. 1988, Hand et
al. 1989, Schade 1990, Neuner et al. 1994). This drug
has shown to have a potent inhibitory action on
the production of IL-12. The suppressive effects of
this drug upon the production of IL-12 may be in-
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hibited by previously existing IFN-γ, which reduces
its utilization in chronic diseases where IFN-γ is
being produced (Moller et al. 1997).
TNF-α synthesis in peritoneal macrophages has
been found to be blocked by pentoxifylline, through
its inhibitory action upon mRNA, through the
inhibition of phosphodiesterase and the increase
in intra-cellular cAMP (Schade 1990, Doherty et al.
1991, Schandené et al. 1992, Loftis et al. 1997).
Pentoxifylline, besides the inhibition of the
synthesis of TNF-α, seems to promote the deviation
of the cellular secretion towards the production of
cytokines of the Th 2 subset, such as IL-4 and IL-
10, inhibiting, on the other hand, the cytokines of
the Th 1 subset, such as IFN-γ and IL-2 (Moller et
al. 1997).
In the present research, it was our intention to
modify in the inflammatory response to the
parasites through the development of an
experimental model of cutaneous leishmaniasis by
L. (L.) amazonensis [L (L)a], in isogenic mice, with
the goal of improving our knowledge of the
pathogenetic mechanisms of the lesion.
MATERIALS AND METHODS
Parasites and animals used - In order to infect
the animals, we used the MHOM/BR/PH8 strain of
L(L)a, isolated from an human case of tegumentary
leishmaniasis. The parasites were maintained in mice
hind footpad, assessed by puncture and replicated
into NNN medium for 10 days, after that grown in
the RPMI 1640 medium (Sigma Chemical Company,
St. Louis, MO, USA). Sixty four female isogenic
mice of the strain C57BL/6 originating from the living
animal reserve of the Pathology Laboratory of the
University of Brasília, were inoculated with 3.106
promastigote forms from the stationary phase.
Treatment with pentoxifylline – Forty animals
were treated with pentoxifylline (Treated Group –
Ptx), using 8 mg/kg/mass, every 12 h, intraperito-
neally, divided in five subgroups, each with eight
animals, six of which were inoculated on the right
ear (Mortatti & Henriques 1990), while two were
inoculated on the right hind footpad in order to
make the limiting dilution assay. The group of ani-
mals treated on the day of the inoculation (24 ani-
mals), was named Ptx-0, and were sacrificed in the
40th, 80th and 120th days after that date (Ptx-040,
Ptx-080 e Ptx-0120, respectively). Another group
with 16 animals began the same treatment 40 days
after the inoculation, and were killed in the 80th
and 120th day after that date and were therefore
named as Ptx-4080 e Ptx-40120, respectively.
Twenty four animals which did not receive any
kind of medicine, became the control group and were
killed in the 40th, 80th and 120th after the inocula-
tion date and were named Ctrl40 , Ctrl80 and Ctrl120.
Sacrifice of the animals and limiting dilution
assay - The evaluation of lesions of the animals
inoculated was conducted through the evolution
of the weight difference between the right and left
ears (Moratti & Henriques 1990) of the sacrificed
mice, and by the histopathologic analyses, by using
a scale from 0 to 6, according to the inflammatory
infiltrate intensity (Magalhães et al. 1986).
The limiting dilution assay was conducted as
described by the autors (Titus et al. 1985, Lima et
al. 1997), and analyzed by the ELIDA© software
(Taswell 1986).
Statistics - In order to evaluate the statistics of
two independent samples the data of the
histopathologic and the weight difference between
the ears, the Mann-Whitney U Test, non-parametric,
was used. At the other sampling times, the non-
parametric test of Kruskal-Wallis was used for k
independent samples and, thereafter, this test was
complemented with the multiple comparisons
method including all the pairs of treatment. In the
study of the weight deviation of the ears the di-
vergent extremes (out-liers) were discarded (Siegel
1977, Campos 1983).
The statistical analysis of the data obtained by
the limiting dilution assay was made using ELIDA©
software (Taswell 1986), which analyses data
through the Poisson distribution, and by the
minimization statistical method of the chi-square
from the data obtained from the plaques, therefore
revealing the estimated number of parasites present
in the analyzed lesions (Titus et al. 1985).
RESULTS
Forty days of infection - According to the
weight difference between the ears, at the 40th day
of infection, a reduction in the average of this
difference was obtained in favor of the animals
treated with pentoxifylline from the beginning of
the infection (Ptx-040) (Fig. 1), even though this
deviation did not have statistical significance (p =
0.120).
According to the histopathological analyses,
some observations had greater prominence than
others. In comparison to the control group, there
was a reduction of the values corresponding to the
whole cellular infiltrated volume – statistically sig-
nificant (p = 0.001) –, to the extent of tissue necro-
sis (p = 0.294) and on the number of vacuolated
macrophages (p = 0.242), in the lesions of the sub-
group of animals that were treated with
pentoxifylline. On the other hand, there was an in-
crease on the amount of neutrophils/granulocytes
– statistically significant (p = 0.032) –, in the sub-
group treated with this drug (Figs 2, 3, 4, 5).
The estimation analyses of the number of para-
sites found on the hind footpad of the animals in-
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Fig. 1: weight difference between animals’ ears
was a reduction in the amount of vacuolated mac-
rophages in the lesions (Figs 2, 3, 4, 5).
The estimated number of parasites found on
the hind footpad of the animals infected with the
limiting dilution assay showed a significant differ-
ence among the treated groups and the control













































































Control Ptx 0 Ptx 40
Treatment groups40 days 80 days 120 days
Fig. 2: evaluation of the whole cellular infiltrate
fected on this site, by the limiting dilution assay,
showed a significant difference among the treated
groups and the control group. In fact, the control
group presented an estimated number of parasite
forms almost two times higher than the treated
group (Fig. 6).
Eighty days of infection - At the 80th day of
infection, according to the weight difference be-
tween the ears, there was a reduction on the aver-
age of this difference among the animals treated
with pentoxifylline from the beginning of the
infection (Ptx-080), in comparison to the control
group, and this was statistically significant
(0.01≤p≤0.001). Moreover, there was an increase of
the average of this difference in the subgroup
treated from the 40th day of infection (Ptx-4080), in
correspondence to the group treated from the
beginning of the infection (Ptx-080), and this
difference was also statistically significant (α=0.009)
(Fig. 1).
The histopathological analyses showed
changes of the same values previously found for
the subgroup treated from the beginning of the
infection (Ptx-080), but none of them were
statistically significant: reduction of the values
corresponding to the whole cellular infiltrate, to the
areas of necrosis extension (0.50≤p≤0.30), and to
the number of vacuolated macrophages in the le-
sions (0.90≤ p ≤0.80) and to the increase in the
amount of neutrophils/granulocytes (0.10≤p≤0.05)
in the subgroup treated with this drug. The analy-
ses of the subgroup treated from the 40th day (Ptx-
4080) in correspondence to the control group did
not show statistical significance, there was an in-
crease in the volume of the whole cellular infiltrate,
of the necrosis area extension, and of the amount
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Fig. 3: evaluation of the necrosis area extension
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crease in the volume of the whole cellular infiltrate
(0.05≤p≤0.02) in comparison to the control group
(α=0.045), of the intensity of the tissue necrosis
(0.02≤p≤0.01), either in comparison to the control
group (α=0.049) or in comparison to the subgroup
treated from the beginning of the infection (Ptx-
0120) (α=0.049). In this subgroup, the level of neu-
trophils/granulocytes was below that observed in
the control group (0.3≤p≤0.2) (Figs 2, 3, 4, 5).
Using the limiting dilution assay, the estimated
number of parasites showed a significant reduction
for the treated subgroup in comparison to the con-
trol group, which presented an estimated number
of parasite forms almost 624 times greater than the
group treated from the beginning of the infection
(Ptx-0120). In the subgroup treated from the 40th
day of infection (Ptx-40120), the estimated number
of parasite forms was reduced by 50%, in compari-
son to the control group (Fig. 6).
DISCUSSION
The subgroup, that received treatment from the
beginning of the infection by  Leishmania (Ptx-0)
presented a significantly lower parasite load than
the control group (Ctrl) during the whole experi-
mental period. There was a decrease in the inflam-
matory process in the animals treated in the Ptx-0
subgroup, in comparison to the control subgroup
(Ctrl), which produced both a reduction in the av-
erage weight deviation of the ears, a decrease in
the whole cellular infiltrate, and of the number of
vacuolated macrophages. The reduction in the quan-
tity of vacuolated macrophages as well as the high
number of neutrophils/granulocytes in the Ptx-0
subgroup suggests the existence of an important
role for these cells in the experimental infection.
The anti-parasitic action of TNF-α resides on a
well known activity, but the authors usually
emphasize that this cytokine seems to have an
efficient role in the modulation of the pro-
inflammatory response only if the levels are
adequate, in other words, when there is no exacer-
bation of its action. High levels of TNF-α leave the
beneficial action over the defense cells with
autocrine and paracrine actions, to exert more gen-
eral actions, of endocrine character, not favoring
the inflammatory process (Vissers et al. 1989,
Jaattela 1991, Abbas et al. 1995, Da-Cruz et al. 1996).
The observations with the Ptx-0  subgroup seem
to result from a pronounced action of the defense
cells stimulated by the levels of TNF-α modulated
by pentoxifylline. This optimal level, might have
allowed a better local action of TNF-α with im-
proved results upon the above mentioned cells,
and, therefore, over the infection. The control of
these levels by the drug seems to exercise some
power over the macrophages, transforming them












































































Control Ptx 0 Ptx 40
Treatment groups40 days 80 days 120 days
mated number of forms almost 43 times higher than
the group treated from the beginning of the infec-
tion (Ptx-080). In addition, the subgroup treated
from the 40th day (Ptx-4080) also demonstrated a
great increase, approximately three times more than
the estimated number of forms detected in the con-
trol group (Fig. 6).
One hundred and twenty days of infection - At
the 120th day of infection the average of the weight
difference between the ears was equivalent between
treated (Ptx-0120) and control group. In the
subgroup treated from the 40th day of infection
(Ptx-40120) there was, on the other hand, a statisti-
cally significant increase (p≤0.001) of the averages
of the differences in comparison to the control
group (α = 0.011) and to the subgroup treated from
the beginning of the infection (Ptx-0120) (α=0.049)(Fig. 1).
Regarding the histopathological analyses, the
subgroup treated from the 40th day (Ptx-40120)
showed a meaningful, statistically significant, in-
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into cells with enhanced phagocytic activity which
would then contribute to the reduction of their own
parasitism (Moll et al. 1990, Abbas et al. 1995). The
role of pentoxifylline in the initial phase of the in-
fection by Leishmania remains unclear, but there
was an explicit improvement in the lesion during
this phase of the experimental model. More studies
measuring these molecules levels at the sites of
infection would be helpful to elucidate our hypoth-
esis.
The inflammatory response to the presence of
Leishmania in the tissues is not usually specific in
the initial phases of infection (Th-0), and remains
this way for approximately 60 days after the infection
(Titus et al. 1989, Scharton & Scott 1993). There
was an increase on the quantity of parasites in the
Ptx-40 subgroup, 80 days after the infection. Dur-
ing this period, the inflammatory response, which
seemed to be non-specific, turned out to be stimu-
lated by pentoxifylline. One possibility would be
an initial deviation towards a Th-2 response,
through the inhibition of the pro-inflammatory
cytokines, such as IL-12, which are essential during
this phase of the infection (Scharton-Kersten et al.
1995, Solbach W & Laskay 1996, Moller et al. 1997).
Confirmatory studies measuring these possible in-
volved  molecules, such as IL-12 in this phase of
inflammation, are necessary to corroborate our
preliminary thoughts
At later stages of the study, after 120 days of
infection, it was noticed that the Ptx-40 subgroup
began to present a lower number of parasites than
the control group. There are reports suggesting
that the level of IFN-γ, and of TNF-α, show a great
increase during the process of infection, reaching
their maximum values in the latest phases (Titus et
al. 1989, Kunkel et al. 1989, Scharton & Scott 1993,
Melby et al. 1994, Reiner et al. 1994). At the present
moment, the pentoxifylline used must have exerted
a modulating activity upon the high level of these
cytokines, making the inflammatory response
adequate to a more effective action, which resulted
in a lower degree of parasitism in the Ptx-40120
subgroup than in the control group. Once again
there is necessary confirmatory studies to eluci-
date these data.
The analyses of the averages of the weight de-
viation of the ears revealed a similar pattern to the
data recorded for the quantity of parasites, hence
the inflammation in the Ptx-40 subgroup was en-
hanced during the course of the experiment. The
histopathological analyses revealed an increase in
both the whole cellular infiltrate and the number of
vacuolated macrophages, after 120 days of infec-
tion, in comparison to control group, demonstrat-
ing a progressive increase in the inflammatory re-
sponse, which was to be expected due to the pos-
sible reestablishment of a Th-1 pattern. The necro-
sis in the Ptx-40 subgroup was enhanced due the
high levels of parasitism, maybe due the possible
initial deviation toward Th-2 in this subgroup, what
surpassed the inhibitory action of pentoxifylline
over elastasis.
During the course of the study, it was observed
that pentoxifylline seems to possess particular ac-
tions and effects when used in a precocious phase
or when used at the first visible signs of the dis-
ease. The response pattern is different in both situ-
ations, so that it reinforces the idea that the host
response to the parasite constitutes a complex game
between pro and anti-inflammatory cytokines, the
results of which may define the prognosis of the
disease.
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